Showing 1711 results
-
Press release /If approved, Scemblix will be indicated for adults with chronic myeloid leukemia (CML), both newly diagnosed and previously treated, expanding access to four times as many patients in EuropeScemblix…
-
Story / -
Story /Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.
-
Press release /Strong growth (cc) in full year sales, core operating income and core EPS[2] Net sales up 5% (cc) and core operating income up 10% (cc) Core operating income margin up 1.3 percentage points (…
-
Story /Novartis investigators find genetic explanations for why some young patients relapse.
-
Story /While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.
-
Story /The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.
-
Story /Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery.
-
Story /Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.